Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda M Gleixner

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Acta Neuropathologica Communications|November 1, 2020
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3Nandini Ramesh, Elizabeth L Daley, Amanda M Gleixner, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Context-dependent Interactors Regulate TDP-43 Dysfunction in ALS/FTLDLongxin Xie, Yuehua Zhu, Bryan T Hurtle, et al.
Nature Communications|December 8, 2019
Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localizationIan Casci, Karthik Krishnamurthy, Sukhleen Kour, et al.
Nature Communications|June 13, 2022
NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubilityAmanda M Gleixner, Brandie Morris Verdone, Charlton G Otte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2025
Developing digital health technologies for frontotemporal degenerationNaomi Nevler, Debra Niehoff, Amanda M Gleixner, et al.
Neuron|March 4, 2019
RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43Jacob R Mann, Amanda M Gleixner, Jocelyn C Mauna, et al.
Molecular Neurodegeneration|December 9, 2022
Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathyBilal Khalil, Deepak Chhangani, Melissa C Wren, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2023
Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domainsLin Guo, Jacob R Mann, Jocelyn C Mauna, et al.
Molecular Cell|January 9, 2026
Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domainsLin Guo, Jacob R Mann, Jocelyn C Mauna, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Acta Neuropathologica Communications|November 1, 2020
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3Nandini Ramesh, Elizabeth L Daley, Amanda M Gleixner, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Context-dependent Interactors Regulate TDP-43 Dysfunction in ALS/FTLDLongxin Xie, Yuehua Zhu, Bryan T Hurtle, et al.
Nature Communications|December 8, 2019
Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localizationIan Casci, Karthik Krishnamurthy, Sukhleen Kour, et al.
Nature Communications|June 13, 2022
NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubilityAmanda M Gleixner, Brandie Morris Verdone, Charlton G Otte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2025
Developing digital health technologies for frontotemporal degenerationNaomi Nevler, Debra Niehoff, Amanda M Gleixner, et al.
Neuron|March 4, 2019
RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43Jacob R Mann, Amanda M Gleixner, Jocelyn C Mauna, et al.
Molecular Neurodegeneration|December 9, 2022
Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathyBilal Khalil, Deepak Chhangani, Melissa C Wren, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2023
Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domainsLin Guo, Jacob R Mann, Jocelyn C Mauna, et al.
Molecular Cell|January 9, 2026
Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domainsLin Guo, Jacob R Mann, Jocelyn C Mauna, et al.
Pageof 2